Dr. Lal Pathlabs Q3 Results 2026 Highlights: Net Profit Falls by 6.41% & Revenue Up 10.57% YoY

Posted by : sachet | Mon Feb 02 2026

Click and Sign Up to Get Live Updates on Q3 Results

Dr. Lal Pathlabs Q3 Results FY26: During Q3 FY26, Dr. Lal Pathlabs’ profit decreased by 6.41% YoY, while revenue increased by 10.57% YoY. The company posted robust numbers, with Q3 PAT at ₹90.50 crores and revenue at ₹659.80 crores. Dr. Lal Pathlabs showed its Q3 results on 30th January 2026.

Table of Contents

Dr. Lal Pathlabs Q3 Results FY26: Extracts of FY25 & FY26

Particulars	Consolidated Figures		Standalone Figures
	31st Dec 2025	31st Dec 2024	31st Dec 2025	31st Dec 2024
Revenue from Operations	₹659.80	₹596.70	₹632.10	₹569.20
Profit Before Tax (PBT)	₹203.70	₹179.10	₹200.30	₹182.30
Profit After Tax (PAT)	₹90.50	₹96.70	₹92.10	₹105.40

Dr. Lal Pathlabs Q3 Results FY26 Highlights (Q3 FY26 vs FY25)

Dr. Lal Pathlabs clocked Q3 FY26 consolidated revenue of ₹659.80 crores vs ₹596.70 crores.
On the profit front, Dr. Lal Pathlabs earned a consolidated PAT of ₹90.50 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹96.70 crore.
According to the consolidated figures, Dr. Lal Pathlabs’ quarterly PAT decreased by 6.41% YoY, while revenue increased by 10.57%.
Dr. Lal Pathlabs clocked Q3 FY26 standalone revenue of ₹632.10 crores vs ₹569.20 crores.
On the profit front, Dr. Lal Pathlabs earned a standalone PAT of ₹92.10 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹105.40 crore.
According to the standalone figures, Dr. Lal Pathlabs’ quarterly PAT decreased by 12.62% YoY, while revenue increased by 11.05%.

Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!

Dr. Lal Pathlabs Share Price Performance

On the opening bell on 2nd February 2026, Dr. Lal Pathlabs shares opened at ₹1,403.50 per share. However, the initial gains have since eroded, and Dr. Lal Pathlabs’ shares are currently trading at ₹1,425.10 per share, which is higher than the opening price.

Considering the long-term performance, Dr. Lal Pathlabs shares have yielded returns of approximately -8.06% over the past 6 months and 1.17% over the past 1 year. Over the maximum timeframe, Dr. Lal Pathlabs shares delivered a 218.08% return to investors.

What Analysts Expect Post Q3 Results?

Following Dr. Lal Pathlabs’ robust Q3 results for FY26, analysts expect its share price to rise. According to analysts, Dr. Lal Pathlabs’ share price could reach ₹1,505.35 per share in the coming year and, in a downturn, hit ₹1,409.850 per share. However, one must ignore stock market volatility and invest in Dr. Lal Pathlabs shares after thorough research.

Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.